TALAN SAS – Trademark Portfolio
Entity Type: 98
TALAN SAS holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include TALAN, PASÀPAS, and TALAN POSITIVE INNOVATION.
14-20 rue Pergolèse
F-75016 Paris
Showing of trademarks Trademarks
Trademark Classifications
TALAN SAS's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does TALAN SAS have?
TALAN SAS has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does TALAN SAS file in?
TALAN SAS files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 38 (Telecommunications), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are TALAN SAS's most well-known trademarks?
TALAN SAS's registered trademark portfolio includes well-known marks such as TALAN, PASÀPAS, and TALAN POSITIVE INNOVATION. These are among 3 currently registered trademarks in the portfolio.
What is TALAN SAS's trademark registration success rate?
TALAN SAS has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.